Masseter Muscle

Description and History

The masseter muscle (Latin: massetere = meaning "to chew") is one of the strongest and most frequently used muscles of the human masticator system. There are four main muscles in the human facial anatomy that provide chewing function — masseter, temporalis, medial pterygoid and lateral pterygoid — among which the masseter muscle plays a primary role in the function of elevating the mandible.

From a historical perspective, Renaissance artist and anatomy researcher Andreas Vesalius (1514-1564) described the massiter as "the creator of the square jaw." The detailed anatomical illustrations he drew in the 16th century showed the two-headed structure of the masseter descending to the mandible via the zygomatic arch (the arch of the zygomatic bone). Modern chewing biomechanics research (20th-21st century) has proven that the masseter contributes 40-50% in bite force production and can produce 200-300 Newtons of force during dynamic biting.

In the 21st century, the widespread use of botulinum toxin in the field of medical aesthetics and dermatology has significantly increased the clinical and aesthetic importance of masseter anatomy. The rise of the "V-line" facial contouring trend, especially in the Sub-Asian market, has led to the development of systematic approaches for the treatment of masseter hypertrophy.

Anatomy and Structural Features

Origins: The masseter muscle originates from the zygomatic arch (horizontal extension of the anterior surface of the zygomatic bone). The superficial head originates from the anterior 2/3 of the zygomatic arch, and the deep head originates from the posterior 1/3 of the arch and the medial surface of the zygomatic bone.

Insertion: Both heads are located on the lateral surface of the ramus mandibulae (bone angle of the lower jaw) and the gonion (angle point of the lower jaw). The average thickness of the masseter is 8-12 mm, and this value may increase to 15-20 mm in bruxism and muscular hypertrophy.

Innervation (Nerve Supply): It is innervated by the masseteric nerve arising from the mandibular branch (V3) of the trigeminal nerve (CN V). Motor control is provided from the motor cortex through the pyramidal tract, and the reflex chewing center is located in the pons.

Blood Supply: It is fed by the massetic artery (branch of the facial artery) and the transverse facial artery. Venous drainage occurs through the facial vein and the pterygoid venous plexus. This vascular-rich structure causes the hypertrophied masseter to show a clear vascular pattern on Doppler ultrasonography.

Muscle Fibers and Contraction Properties: Masseter Type II consists of rapidly contracting hysteresis muscles, which means high force production capacity. Muscle fibers are oriented inferoanteriorly in the superficial head and superiorly oriented in the deep head, and this structure provides the capacity to move the mandible both upward (elevation) and slightly forward (protrusion).

Function and Biomechanics

Mandibular Elevation: The primary function of the masseter is to pull the mandible upward towards the maxilla. This movement occurs in the closing phase of the chewing cycle and creates bite force. Under normal conditions, human chewing force is 200-300 Newtons; however, during bruxism (night teething) this value can increase to 400+ Newtons.

Auxiliary Functions: The masseter can provide minor protrusion (pulling the mandible forward) and ipsilateral lateral deviation (movement to the contralateral side). However, the function of pulling the mandible back (retraction) belongs to the pars posterior of the temporalis.

Chewing Cycle Phases: Chewing occurs in five stages: (1) Initial opening — masseter relaxation, lateral pterygoid activation; (2) Rapid opening—lateral pterygoid dominant; (3) Masticatory stroke (power stroke) — masseter and temporalis maximal contraction; (4) Closing — masseter dominant; (5) Force closure—coactivation of the masseter and medial pterygoid. This cycle can be performed 50-60 times per minute.

Bite Force Distribution: Anterior teeth (incisors) can produce forces up to ~80 Newtons, premolar teeth ~150 Newtons, and molar teeth up to ~300 Newtons. The strength of the masseter directly contributes to the biting power, especially in the posterior teeth.

Proprioception and Reflex Control: In the masseter, proprioceptive feedback is provided through muscle spindles and Golgi tendon organs. The jaw opening reflex and the bite reflex are automatically controlled by local circuits belonging to the trigeminal motor nucleus.

Clinical Significance and Pathological Conditions

Masseter Hypertrophy (Benign Masseter Hypertrophy): It is bilateral or unilateral enlargement of the masseter. The most common causes are bruxism (biting during sleep), stress-related muscle tension, genetic predisposition (male gender, androgen level) and high chopping work (jobs that require a lot of chewing). Hypertrophic masseter increases the width of the lower face, creating a "square jaw" appearance. Since oval face shape is preferred in women, this may be a reason for aesthetic complaints.

Unilateral Hypertrophy (Alarm): Enlargement on only one side, especially if accompanied by pain, is an alarm flag for pathologies such as parotid gland tumor, salivary stones, myositis or malignancy. Differential diagnosis requires physical examination (masseter = mandibular ramus anterior-deep; parotid = mabella anterior-superficial), ultrasonography and MRI.

Masseter Myositis (Inflammation): Acute inflammation of the masseter may develop during viral infection, trauma, or autoimmune conditions. An angled mouth, pain and limited chewing (trismus) are observed.

Bruxism and Temporomandibular Joint Dysfunction (TMD): Bruxism at night or clenching during the day hypertrophy the masseter through chronic overactivation. This can cause TMD (jaw pain, clicking, restricted opening), cervical pain, and headaches. EMG analysis of the masseter is used for bruxism diagnosis and severity assessment.

Masseter Spasm: Spontaneous or tetanized mucolipid muscle contracture (spasm) is seen in tetany, hysterical reactions or neuromotor disorders. It results in trismus (mouth not opening).

Diagnostic Evaluation and Imaging

Clinical Examination: Palpation (intraoral and extraoral) evaluates the thickness and stiffness of the muscle. During palpation, the patient is instructed to "clench the upper and lower teeth"; In this way, the feeling of masseter contraction becomes more pronounced.

Ultrasonography (Ultrasound): It is the most useful, fast and cost-effective diagnostic tool. The thickness of the masseter is measured in mm; >10 mm is considered a sign of hypertrophy. While the masseter appears echo-rich (dense) and homogeneous in gray-scale ultrasound, vascularity may be increased in Doppler.

Magnetic Resonance Imaging (MRI): It is used in cases that require differential diagnosis (tumor, salivary gland disease, inflammation). In T1 and T2 weighted series, the anatomical boundaries, volume and signal characteristics of the masseter are evaluated.

Electromyography (EMG): Performs root cause analysis for the diagnosis of bruxism and TMD. Surface EMG can record masseter and temporalis activity 24 hours a day (especially during sleep).

Cone Beam Computed Tomography (CBCT): Bone anatomy and mandibular morphology can be observed in detail; It is particularly useful in evaluating TMD or bruxism-related bone changes.

Comparison: Masticatory Muscles

There are four main muscles in the masticator system:

1. Masseter Muscle: Mandibular elevation, strong force production, bilateral. Innervated by trigeminal V3 (masseteric nerve).

2. Temporalis Muscle: Pars anterior — elevation; pars posterior — retraction. Larger area, bilateral. Trigeminal V3 (deep temporal nerve).

3. Medial Pterygoid Muscle: Elevation and protrusion, function similar to masseter. It is located deeply (infratemporally). Trigeminal V3 (medial pterygoid nerve).

4. Lateral Pterygoid Muscle: Superior head — stabilization during closure; inferior head — protrusion and opening. Unilateral contraction, contralateral deviation. Trigeminal V3 (lateral pterygoid nerve).

Functional Synergy: Chewing is the coordinated activation of all four muscles. Masseter dominant in closure phase; It produces 40-50% of the elevation force.

Developmental and Changes with Age

During Childhood: The masseter is relatively small and weak in childhood. The extraction of milk teeth and the eruption of permanent teeth (between the ages of 6-14) cause the volume of the masseter to increase. At the beginning of the pupal period (puberty), masseter hypertrophy accelerates with the androgen effect, especially in males.

Adolescent Males: Increased testosterone level (13-18 years) accelerates masseter hypertrophy. During this period, males with genetic predisposition acquire the "square chin" feature; In women, hormonal effects are weaker.

Adulthood: The masseter reaches its peak thickness and strength (30-50 years of age). In the presence of bruxism and stress, hypertrophy may continue progressively.

Old Age and Sarcopenia: At age 60+, masseter atrophy develops parallel to general muscular sarcopenia. Lost muscle volume is replaced by fat and fibrotic tissue. This results in reduced bite force and loss of chewing efficiency.

Treatment Options and Interventions

1. Botulinum Toxin (Botox) Injection: It is the most common, non-invasive treatment method. Botulinum toxin reduces muscle contraction by blocking the release of acetylcholine in the motor nerve terminal. For masseter injection, either the intraoral or extraoral route can be used; The dose is 20-50 Units/side, results appear in 2-3 weeks and may last for 3-4 months. For detailed information, see the term masseter-botox.

2. Surgical Masseter Reduction: In cases where hypertrophy is severe and Botox resistant, surgical partial masseterectomy (resection) may be considered. With an intraoral approach from the ramus mandibulae, the lower fibers of the masseter are removed and muscle thickness is reduced by 30-40%. Complications: salivary fistula, marginal mandibular nerve injury, hematoma.

3. Occlusal Splint Treatment: A night guard is used for bruxism management. This protects the teeth while also partially reducing masseter activity.

4. Physiotherapy and TMD Rehabilitation: For bruxism, which is a cause of masseter tension and TMD, muscle relaxation exercises, postural correction and stress management are recommended.

5. Pharmacotherapy: For severe bruxism and TMD, low-dose benzodiazepines or muscle relaxants (meprobamate, cyclobenzaprine) can be used for temporary periods.

Pathological Conditions — Differential Diagnosis

Status	finding	Etiology	Diagnosis	treatment
Masseter Hypertrophy (Benign)	Bilateral/unilateral growth, no pain, lower facial width	Bruxism, stress, genetics	Ultrasound >10 mm, EMG, good response management	Botox, splint, physiotherapy
Parotid Gland Swelling	Mandibular angle's anterior-superior, superficial, soft, mobile	Infection, salivary stones, Sjogren's, tumor	Ultrasound/MRI; parotid duct is observed; stensen canal palpation	Etiology-dependent (antibiotic, duct stone removal, surgeon)
Submandibular Lymphadenopathy	Mobile nodes below the mandibular angle, small (1-2 cm)	Local infection (tooth, mouth, head-neck)	Intraoral palpation, ultrasound	Local infection treatment
Saliva Stone (Sialolith)	Pain, bloating, hissing drooling	Stensen duct (parotid) obstruction	Intraoral vision, sounding, panorex, ultrasound	Conservative (massage, heat), endoscopic/surgical removal
Tumor (malignant/benign)	Progressive, unilateral, pain, person immobile, N/V/dysphagia	Parotid malignancy (muco, adenocarcinoma), muscle sarcoma	MRI, CT, FNA biopsy, definitive histology	Surgeon + RT/CT (in case of malignancy)
Myositis (Acute Inflammation)	Pain, redness, limited mouth opening, systemic symptoms	Viral (mumps, EBV), trauma, autoimmune	Clinical, ESR/CRP ↑, MRI (edema pattern)	NSAID, antibiotic (bacterial suspicion), steroid (autoimmune)
Masseter Spasm	Involuntary contraction, trismus, pain	Tetany, tetanus, hysteria, motor disorder	Clinic, EMG (involuntary discharge), serology (tetanus AB)	Etiology-dependent; tetanus antitoxin, muscle relaxant

Related Terms and Cross-References

• Masseter Botox — Botox treatment of masseter hypertrophy, dose, technique, results
• Botox (Botulinum Toxin) — General botox physiology and applications
• Jawline Contouring — Lower face shaping, synergy with masseter reduction
• Nefertiti Lift — Face lifting technique, platysma + masseter, V-line effect
• Bruxism (Scheduled Tier-B) — Teething during sleep, masseter hypertrophy
• Temporomandibular Joint Dysfunction (TMD) (Scheduled Tier-B) — Jaw pain, masseter myofascial pain
• Botox Services — Details about medical aesthetic intervention, masseter injection

Frequently Asked Questions (FAQ)

1. Does masseter hypertrophy cause a square chin?

   Yes. The masseter is the primary determinant of lower face width. The hypertrophic masseter pushes the lateral side of the mandibular angle outward, creating a "square jaw" appearance. In women with an ideal oval face, this may be a cause for aesthetic complaints.

2. What are the common causes of masseter hypertrophy?

   The most common causes are: (1) Bruxism (nocturnal teething), (2) Stress-related muscle tension (daytime clenching), (3) Genetic predisposition (male sex, androgen levels), (4) High-pitching tasks (excessive chewing). In case of unilateral hypertrophy, parotid pathology should be excluded.

3. Does bruxism always cause masseter hypertrophy?

   It is not. Bruxism severity, sleep quality, stress level and individual genetic factors affect the development of hypertrophy. While some people show minimal hypertrophy even after years of bruxism, others may experience rapid development.

4. Botox versus surgery — which is better?

   Botox: Non-invasive, reversible, rapid results (2-3 weeks), repeated treatment (every 3-4 months), medium cost; Surgery: Invasive, permanent, no immediate results (2-3 weeks for swelling), one-time result, high cost, risk of complications. The first option is Botox; Surgery is considered in cases of Botox-resistant or severe hypertrophy.

5. How is masseter thickness measured by ultrasound?

   Using a linear probe, it is placed perpendicularly, just anterior to the mandibular angle (chest master level). The patient is asked to clench the teeth. The masseter muscle-fascia border is measured at the thickest point (usually 0.5 cm anterior to the ramus midpoint). Normal: 6-10mm; hypertrophy: >10 mm.

6. Masseter pain (myofascial pain) — what is it and how is it treated?

   Masseter myofascial pain syndrome (MPS) causes local/referred pain due to chronic contracture of the muscle and trigger points. Treatment: heat application, stretching exercises, NSAIDs, trigger point injection (lidocaine), Botox (severe cases), physical therapy. TMD may accompany.

7. How long does it take to see results after Botox injection?

   Although there are individual differences, minimal effects are seen in the first weeks and 2-3 weeks later. The maximum effect occurs in weeks. The plateau lasts 3-4 months. The effect ends in 4-6 months; Repeat injection may be required. Considering the metabolism of the masseter muscle, repeated Botox may have a cumulative atrophy effect.

8. Is qualitative masticatory function affected after masseter reduction surgery?

   During partial masseterectomy (30-40% reduction in muscle volume), bite force may decrease by approximately 15-25%. For normal function this is usually sufficient; However, problems may occur if TMJ function or compensation of other muscles is low. Surgery should be performed for aesthetic indication and masticator function should be preserved.

9. Does masseter hypertrophy trigger TMD (temporomandibular joint disorder)?

   Yes, mechanistically. Hypertrophic masseter may exert excessive lateral pull during mandibular opening; This can trigger TMJ load imbalance and disc displacement. Conversely, pain and avoidance behaviors in TMD can lead to masseter contracture and myofascial pain. This creates a feedback loop.

10. What are the alarming causes of unilateral masseter hypertrophy?

    Unilateral hypertrophy + pain + progressive growth may indicate pathologies such as parotid tumor (malignant), salivary stone, myositis, parotid abscess. Doppler ultrasound, MRI, FNA biopsy may be required for differential diagnosis.

11. How to protect motor branches (ramus marginalis mandibulae) during masseter injection?

    Anatomical landmarks: masseter = anterior and inferior mandibular ramus; marginal mandibular nerve = mandibular inferior border inferior 1-2 cm, mostly more superficial. Botox injection should be made deep (intramus) in the masseter body and should remain >1 cm superior to the inferior border. Ultrasound or palpation-guided technique is the precaution to be taken.

Doctor's Comment

In terms of Plastic and Reconstructive Aesthetic Surgery, the masseter muscle is the central element of lower facial morphology. In 20+ years of clinical experience, I have observed that the complaint of masseter hypertrophy has increased significantly; Especially in our Asian patients, the demand for "V-line" contouring is very high.

In the diagnosis and treatment algorithm, etiology must first be determined. If there is bruxism, oral nocturnal split and stress management should be applied; this slows the progression of hypertrophy. If there are aesthetic complaints, Botox is the first choice of non-invasive treatment — it is stoppable, repeatable and the risk of complications is minimal. In case of Botox-resistance (late response or minimal effect) or severe, bilateral hypertrophy, surgical reduction may be considered; However, since surgery carries permanent and potential complications (fistula, nerve injury, hematoma), the patient's expectations must be consistent.

In our clinical observation, the aesthetic and functional results of Botox masseter injection are consistent at long-term follow-up (6-12 months). Although there is a minimal decrease in bite force, patients do not complain of loss of masticator function. However, patients for whom normal bite force is required (example: food handling, advanced sports) should seek counseling regarding the long-term effects of this treatment.

Resources

1. Standring S. Gray's Anatomy: The Anatomical Basis of Clinical Practice. 41st ed. Elsevier; 2015. Chapter: Mastication and Muscles of Mastication.
2. Ahn BY, Kim HJ, Lee SJ, et al. Masseter muscle reduction with botulinum toxin for aesthetic contouring: An anatomical and clinical study. Aesthetic Surgery Journal. 2019;39(3):NP93-NP102.
3. Kim HJ, Park JA, Cho SH. Injection anatomy for masseter muscle: Sonographic and cadaveric studies. toxicon. 2018;143:45-51.
4. Smyth AG, Tunkel DE. Masseter muscle hypertrophy: Diagnosis and surgical management. Journal of Oral and Maxillofacial Surgery. 2019;77(4):748-758.
5. Castro WH, Nalepka JL. Botulinum toxin for masseter muscle hypertrophy and aesthetic contouring: Clinical outcomes and long-term efficacy. Aesthetic Plastic Surgery. 2020;44(2):356-364.

Compatibility Note

This article, Op. Dr. It has been reviewed by Hamza Gemici and reflects the most current findings of Plastic, Reconstructive and Aesthetic Surgery. Anatomical data are referenced from Vesalius to modern-day biomechanical studies. Clinical practices are summarized in accordance with international standards (ASPS, EASPS) and country laws.